Search results
Results from the WOW.Com Content Network
It sure has been a good month for genetics company Sequenom (NAS: SQNM) . Fresh off the heels of strong sales of its MaterniT21 PLUS prenatal test, the company happily issued the results of a ...
Sequenom, Inc. is an American company based in San Diego, California.It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiary, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy ...
In 2011, Sequenom announced the launch of MaterniT21, a non-invasive blood test with a high level of accuracy in detecting Down syndrome (and a handful of other chromosomal abnormalities). As of 2015, there are five commercial versions of this screen (called cell-free fetal DNA screening) available in the United States. [citation needed]
This page was last edited on 8 January 2013, at 14:12 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may ...
Test results can come back as “atypical” for many reasons, such as noncancerous growths like uterine fibroids. But atypical results can also be associated with a “very high rate” of ...
For premium support please call: 800-290-4726 more ways to reach us
An example of an algorithm for determining the indication for prenatal genetic testing for trisomy 21 (Down syndrome), wherein the genetic blood test (in center) is performed by detecting cffDNA in a blood sample from the mother. [60] Trisomy 21. Fetal trisomy of chromosome 21 is the cause of Down's syndrome.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.